Showing results (81-90 of 220) with videos related to
Sort By:
Pageof 22
Gan to Kagaku Ryoho. Cancer & Chemotherapy|January 1, 1991
[5'-deoxy-5-fluorouridine (5'-DFUR), mitomycin C (MMC), etoposide and medroxy progesterone acetate (MPA) in a previously treated patient with advanced breast cancer]K Yoshinaka, M Yagi, S Ohtagaki, et al.Journal of Clinical Pathology|May 3, 2002
Lack of CD34 positive stromal cells within angiomyomas (vascular leiomyomas)H Nakayama, H Enzan, E Miyazaki, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|April 1, 1995
[Significance of tumor angiogenesis as an independent prognostic factor in axillary node-negative breast cancer]K Inada, M Toi, S Hoshina, et al.Histology and Histopathology|December 4, 2004
Review of mucinous tubular and spindle-cell carcinoma of the kidney with a focus on clinical and pathobiological aspectsN Kuroda, M Toi, M Hiroi, et al.Cancer|July 1, 1991
Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancerH Mukaida, M Toi, T Hirai, et al.Journal of Surgical Oncology|January 1, 1997
Outcome of surgical resection for chest wall recurrence in breast cancer patientsM Toi, S Tanaka, M Bando, et al.Gan to Kagaku Ryoho. Cancer & Chemotherapy|February 1, 1997
[Determination of intratumoral estrone (E1) and estradiol (E2) in primary breast cancer tissues by sensitive HPLC-RIA]N Nagaya, M Toi, S Sunahara, et al.British Journal of Cancer|July 20, 2000
Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentrationT Ueno, M Toi, M Koike, et al.Histology and Histopathology|June 7, 2003
Review of renal oncocytoma with focus on clinical and pathobiological aspectsN Kuroda, M Toi, M Hiroi, et al.Anticancer Research|January 11, 2000
Induction of G1 arrest and selective growth inhibition by lactacystin in human umbilical vein endothelial cellsS I Kumeda, A Deguchi, M Toi, et al.Pageof 22